Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Net Income (2021 - 2025)

PAVmed (PAVM) has 5 years of Net Income data on record, last reported at -$6.0 million in Q3 2025.

  • For Q3 2025, Net Income changed N/A year-over-year to -$6.0 million; the TTM value through Sep 2025 reached $1.4 million, changed N/A, while the annual FY2024 figure was $28.4 million, 135.86% up from the prior year.
  • Net Income reached -$6.0 million in Q3 2025 per PAVM's latest filing, up from -$12.3 million in the prior quarter.
  • Across five years, Net Income topped out at $18.6 million in Q1 2025 and bottomed at -$29.9 million in Q3 2022.
  • Average Net Income over 5 years is -$15.0 million, with a median of -$17.6 million recorded in 2023.
  • Peak YoY movement for Net Income: tumbled 129.68% in 2022, then skyrocketed 200.6% in 2025.
  • A 5-year view of Net Income shows it stood at -$19.7 million in 2021, then decreased by 24.86% to -$24.6 million in 2022, then rose by 29.16% to -$17.4 million in 2023, then surged by 106.56% to $1.1 million in 2024, then plummeted by 626.44% to -$6.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$6.0 million in Q3 2025, -$12.3 million in Q2 2025, and $18.6 million in Q1 2025.